New Antimalarials from Plant-Pathogenic Fungi
来自植物病原真菌的新型抗疟药
基本信息
- 批准号:6899703
- 负责人:
- 金额:$ 17.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-01 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by the applicant): Plasmodium falciparum, which often causes fatal cerebral malaria, especially among children, has developed resistance to the one very effective antimalarial drug chloroquine and is developing resistance to other antimalarial drugs introduced more recently such as mefloquine and halofantrin. Therefore, there is an urgent need to develop alternative drugs to counter this trend.
Natural products isolated from higher plants, such as quinine and artemisinin, have provided effective drugs against malaria. In the last few decades a large number of plants, including those traditionally used, have been evaluated for their antimalarial activity. However, no new drug candidates and very few lead compounds have emerged from these efforts. Because of the ease of rapid mass production and good chemical diversity, fungi remain a good and attractive natural source for biologically active compounds. Fungi have provided the majority of agents and lead compounds currently used against bacterial infections. A few of these antibiotics are effective in combination with conventional antimalarial drugs against drug-resistant falciparum malaria. However, only very few extracts or secondary metabolites of fungi have been systematically evaluated for their antimalarial activity.
Plant pathogenic fungi are known to release phytotoxic secondary metabolites, which disrupt biochemical processes in plant cells. Genomic and recent biochemical studies have shown that there are a number of plant-like metabolic pathways in the malaria parasite. Our preliminary results indicate that plant pathogenic fungi can be a good source of antimalarial compounds. The purpose of this proposal is to expand on these results and to identify antimalarial compounds from plant pathogenic fungi and their preliminary evaluation as new clinically useful antimalarial agents.
描述(由申请人提供):恶性疟原虫经常导致致命的脑疟疾,特别是在儿童中,已对一种非常有效的抗疟药物氯喹产生耐药性,并正在对最近引入的其他抗疟药物(如甲氟喹和氟苯醚)产生耐药性。因此,迫切需要开发替代药物来应对这一趋势。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Biologically active tetranorditerpenoids from the fungus Sclerotinia homoeocarpa causal agent of dollar spot in turfgrass.
- DOI:10.1021/np900334k
- 发表时间:2009-12
- 期刊:
- 影响因子:5.1
- 作者:Herath, H. M. T. Bandara;Herath, Wimal H. M. W.;Carvalho, Paulo;Khan, Shabana I.;Tekwani, Babu L.;Duke, Stephen O.;Tomaso-Peterson, Maria;Nanayakkara, N. P. Dhammika
- 通讯作者:Nanayakkara, N. P. Dhammika
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NP D NANAYAKKARA其他文献
NP D NANAYAKKARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NP D NANAYAKKARA', 18)}}的其他基金
相似海外基金
Development of a New Class of Broad-Stage Antimalarial Agents
新型多阶段抗疟药物的开发
- 批准号:
nhmrc : 2000087 - 财政年份:2021
- 资助金额:
$ 17.94万 - 项目类别:
Development Grants
Discovery of Small Molecules as Antimalarial Agents
作为抗疟剂的小分子的发现
- 批准号:
10312722 - 财政年份:2021
- 资助金额:
$ 17.94万 - 项目类别:
Synthetic Antibody Mimics as Antimalarial Agents
作为抗疟剂的合成抗体模拟物
- 批准号:
10161881 - 财政年份:2020
- 资助金额:
$ 17.94万 - 项目类别:
New aminobenzimidazole antimalarial agents with a novel mechanism of action
具有新作用机制的新型氨基苯并咪唑抗疟药
- 批准号:
nhmrc : GNT1163235 - 财政年份:2019
- 资助金额:
$ 17.94万 - 项目类别:
Project Grants
Investigating the pharmacology of 8-Aminoquinoline antimalarial agents.
研究 8-氨基喹啉抗疟药的药理学。
- 批准号:
2269400 - 财政年份:2019
- 资助金额:
$ 17.94万 - 项目类别:
Studentship
Targeting the Plasmodium falciparum Metalloaminopeptidases for Development of New Antimalarial Agents
针对恶性疟原虫金属氨基肽酶开发新型抗疟药物
- 批准号:
nhmrc : 1063786 - 财政年份:2014
- 资助金额:
$ 17.94万 - 项目类别:
Project Grants
Search for antimalarial agents from microbial sources
从微生物来源寻找抗疟药物
- 批准号:
25860082 - 财政年份:2013
- 资助金额:
$ 17.94万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Defining the targets of broad intervention antimalarial agents
确定广泛干预抗疟药物的目标
- 批准号:
8892056 - 财政年份:2013
- 资助金额:
$ 17.94万 - 项目类别:
Defining the targets of broad intervention antimalarial agents
确定广泛干预抗疟药物的目标
- 批准号:
9109547 - 财政年份:2013
- 资助金额:
$ 17.94万 - 项目类别: